NCT07270978
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07270978
Title Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS (AML-MDS 001)
Acronym AML-MDS 001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Virginia
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Virginia RECRUITING Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field